The results indicated that patients with a high-risk score were in an immune “cold” phenotypic state, with low levels of immune cell infiltration (e.g., CD4+) and cancer-immunity cycle steps as well as reduced antigen-presenting capacity (e.g., aDCs). This evidence concerns the gene CD4 and cancer.